Effect of a Nutritional Product Containing Carob Extract on Carbohydrate Metabolism in Glucose-intolerant Subjects
Randomized Clinical Trial on the Effect of a Nutritional Product Containing Carob Extract (NUTIFOOD) on Carbohydrate Metabolism in Glucose-intolerant Subjects
Universidad Católica San Antonio de Murcia
30 participants
Jan 26, 2026
INTERVENTIONAL
Conditions
Summary
Randomized, controlled, double-blind clinical trial with two parallel arms based on the product consumed (experimental product and placebo product) and conducted at a single center, to measure the efficacy of the liquid NUTIFOOD product (nutritional product with carob extract) on carbohydrate metabolism.
Eligibility
Inclusion Criteria8
- Subjects of both sexes aged 18-65 years.
- Diagnosis of glucose intolerance according to the American Diabetes Association (at least one of the following criteria):
- Impaired fasting glucose (100-125 mg/dl)
- Impaired glucose tolerance (oral glucose tolerance test with 2-hour plasma glucose between 140-199 mg/dl)
- Glycated hemoglobin between 5.7% and 6.4%
- Body mass index between 20-35 kg/m².
- Stable dietary habits: no weight gain or loss greater than 5 kg in the last ten weeks.
- Volunteers capable of understanding the clinical study and willing to comply with the study procedures and requirements.
Exclusion Criteria7
- Use of medications that may interfere with glucose metabolism.
- Subjects with a history of any type of hepatic or renal disease.
- Alcohol consumption greater than 20 g/day.
- History of allergic hypersensitivity or poor tolerance to any component of the study products.
- Participation in another clinical trial within the three months prior to the study.
- Lack of willingness or inability to comply with clinical trial procedures.
- Pregnant or breastfeeding women.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Participants will consume two doses per day. The product should be taken 30 minutes before the two main meals of the day.
Participants will consume two daily doses of the placebo product. The product should be taken 30 minutes before the two main meals of the day.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07420998